TELA (STOCKS)
TELA Bio, Inc. Common Stock
$0.680000
-0.040200 (-5.58%)
Prev close: $0.720200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Heather C. Getz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $29.76M
- Employees
- 209
- P/E (TTM)
- -0.88
- P/B (TTM)
- -1.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.20 | $-0.18 | -0.0182 | -10.01% |
|
Mar 2026 (Q1)
|
$-0.21 | $-0.19 | -0.0180 | -9.38% |
|
Dec 2025 (Q4)
|
$-0.17 | $-0.19 | +0.0163 | +8.75% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.20 | +0.0130 | +6.40% |
Financial Statements
| Revenues | $79.91M |
| Benefits Costs and Expenses | $120.82M |
| Cost Of Revenue | $25.72M |
| Costs And Expenses | $120.82M |
| Gross Profit | $54.19M |
| Nonoperating Income/Loss | -$6.90M |
| Operating Expenses | $88.20M |
| Research and Development | $9.54M |
| Other Operating Expenses | $78.66M |
| Operating Income/Loss | -$34.01M |
| Income/Loss From Continuing Operations After Tax | -$41.18M |
| Income/Loss From Continuing Operations Before Tax | -$40.91M |
| Income Tax Expense/Benefit | $265.00K |
| Net Income/Loss | -$41.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$41.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$41.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.77 |
| Diluted Earnings Per Share | -$0.77 |
| Basic Average Shares | 161,688,658 |
| Diluted Average Shares | 161,688,658 |
| Assets | $59.74M |
| Current Assets | $54.49M |
| Accounts Receivable | $9.64M |
| Inventory | $11.06M |
| Other Current Assets | $33.80M |
| Noncurrent Assets | $5.25M |
| Fixed Assets | $2.05M |
| Intangible Assets | $1.17M |
| Other Non-current Assets | $2.03M |
| Liabilities | $75.60M |
| Current Liabilities | $18.22M |
| Accounts Payable | $2.88M |
| Wages | $7.16M |
| Other Current Liabilities | $8.17M |
| Noncurrent Liabilities | $57.39M |
| Equity | -$15.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$15.87M |
| Liabilities And Equity | $59.74M |
| Net Cash Flow From Operating Activities | -$31.14M |
| Net Cash Flow From Operating Activities, Continuing | -$31.14M |
| Net Cash Flow From Investing Activities | $933.00K |
| Net Cash Flow From Investing Activities, Continuing | $933.00K |
| Net Cash Flow From Financing Activities | $25.56M |
| Net Cash Flow From Financing Activities, Continuing | $25.56M |
| Net Cash Flow | -$4.65M |
| Net Cash Flow, Continuing | -$4.65M |
| Comprehensive Income/Loss | -$41.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$41.19M |
| Other Comprehensive Income/Loss | -$8.61M |